We are live on
!
Find out more
BHIA
Birch Hill Investment Advisors Portfolio holdings
AUM
$2.47B
1-Year Est. Return
20.95%
This Fund
S&P 500
This Quarter
Est. Return
+7.08%
1 Year Est. Return
+20.95%
3 Year Est. Return
+73.74%
5 Year Est. Return
+103.45%
10 Year Est. Return
+381.47%
AUM
$1.86B
AUM Growth
+$106M
(+6%)
Cap. Flow
-$5.26M
Cap. Flow
% of AUM
-0.28%
Top 10 Holdings %
Top 10 Hldgs %
39.7%
Holding
165
New
8
Increased
33
Reduced
62
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$8.24M |
| 2 |
Uber
UBER
|
+$5.3M |
| 3 |
Masco
MAS
|
+$4.56M |
| 4 |
Organon & Co
OGN
|
+$2.34M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$4.34M |
| 2 |
Donaldson
DCI
|
+$3.29M |
| 3 |
Johnson & Johnson
JNJ
|
+$2.98M |
| 4 |
Labcorp
LH
|
+$2.61M |
| 5 |
Procter & Gamble
PG
|
+$2.47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.22% |
| 2 | Technology | 17.18% |
| 3 | Healthcare | 15.57% |
| 4 | Consumer Discretionary | 11.65% |
| 5 | Consumer Staples | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Honeywell
HON
$78B
| $231K | 0.01% |
1,117
| – | – |
|
152
Altria Group
MO
$114B
| $229K | 0.01% |
4,800
| – | – |
|
153
iShares MSCI ACWI ex US ETF
ACWX
$11.9B
| $223K | 0.01% |
3,883
| – | – |
|
154
Canadian National Railway
CNI
$76.6B
| $221K | 0.01% |
2,095
| – | – |
|
155
CSX Corp
CSX
$93.1B
| $220K | 0.01% |
6,846
| – | – |
|
156
iShares Russell 1000 ETF
IWB
$50.2B
| $220K | 0.01% |
910
| – | – |
|
157
Paychex
PAYX
$42.7B
| $215K | 0.01% |
+2,000
| New | +$201K |
|
158
General Mills
GIS
$19.7B
| $212K | 0.01% |
3,480
| – | – |
|
159
UnitedHealth
UNH
$370B
| $208K | 0.01% |
+519
| New | +$207K |
|
160
Waters Corp
WAT
$39.9B
| $207K | 0.01% |
+600
| New | +$190K |
|
161
Morgan Stanley
MS
$340B
| $205K | 0.01% |
+2,238
| New | +$192K |
|
162
Tesla
TSLA
$1.3T
| $204K | 0.01% |
900
| – | – |
|
163
New York Times
NYT
$10.2B
| – | – |
-4,150
| Closed | -$210K |
|
|
PRTC
164
DELISTED
PureTech Health
PRTC
| – | – |
-302,000
| Closed | -$1.67M |
|
165
WEC Energy
WEC
$35.1B
| – | – |
-2,200
| Closed | -$206K |
|
Similar funds
SCM
TW
M
SG
FFA
GWM
Q
SIM
Birch Hill Investment Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, Birch Hill Investment Advisors held 165 positions worth $1.86B, up 6% from $1.76B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Birch Hill Investment Advisors's Q2 2021 filing shows 8 new, 33 increased, 62 reduced and 3 closed positions. Its largest new stake was Organon & Co: 71,186 shares worth $2.15M. The largest sale was Merck, an estimated $4.34M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- Birch Hill Investment Advisors's largest Q2 2021 buy was Organon & Co: 71,186 shares worth $2.15M.
- Birch Hill Investment Advisors added most to Vertex Pharmaceuticals in Q2 2021, an estimated $8.24M increase.
- Birch Hill Investment Advisors's biggest Q2 2021 reduction was Merck, cutting an estimated $4.34M.
- Birch Hill Investment Advisors fully exited PureTech Health in Q2 2021, selling an estimated $1.67M.
- Birch Hill Investment Advisors's ten largest holdings make up 40% of its $1.86B portfolio in Q2 2021.
- Birch Hill Investment Advisors opened 8 new positions and closed 3 in Q2 2021.
- Birch Hill Investment Advisors's portfolio value rose 6% quarter-over-quarter to $1.86B.
Based on Birch Hill Investment Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.